24. Hank JA, Robinson RR, Surfus J, Mueller BM, Reisfeld RA, Cheung NK, Sondel PM: 
Augmentation of antibody dependent cell mediated cytotoxicity following in vivo 
therapy with recombinant interleukin 2. Cancer Res 50:5234, 1990. 
25. Handgretinger R, Bruchelt G, Daurer B, Lang P, Dopfer R, Reisfeld RA, Treuner J, 
Niethammer D: The role of interferons in neuroblastoma: Part 2: Immunomodulatory 
effects. Klin Pediatr 202:206, 1990. 
26. Handgretinger R, Kimmig A, Lang P, Daurer B, Kuci S, Bruchelt G, Treuner J, 
Niethammer D: Interferon-gamma upregulates the susceptibility of human 
neuroblastoma cells to interleukin-2-activated natural killer cells. Nat Immun, Cell 
Growth Regul 8/4:189, 1989. 
27. Duan DS, Farmer D, Rayner AA, Sadee W: Cytotoxicity of lymphokine-activated killer 
cells against human neuroblastoma cells: modulation by neuroblast differentiation. Med 
Ped Oncol 18:339, 1990. 
28. Nishihara K, Miyatake S, Kikuchi H, Barth RF, Wilkie N: Tumorigenicity and 
immunogenicity of IFN-gamma and IL-2 gene-transfected tumor cells. Proc Annu Meet 
Am Assoc Cancer Res 32:A1370, 1991 (abstr.). 
29. Watanabe Y, Kuribayashi K, Miyatake S, Nishihara K, Nakayama E-I, Taniyama T, 
Sakata T-A: Exogenous expression of mouse interferon gamma cDNA in mouse 
neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor 
immunity. Proc Natl Acad Sci USA 86:9456, 1989. 
30. Favrot MC, Floret D, Negrier S, Cochat P, Bouffet E, Dacheng Z, Franks CR, Bijman 
T, Brunat-Mentigny M, Philip I, Philip T: Systemic interleukin-2 therapy in children 
with progressive neuroblastoma after high dose chemotherapy and bone marrow 
transplantation. Bone Marrow Transpl 4/5:499, 1989. 
31. Favrot MC, Michon J, Floret D, Cochat C, Negrier S, Mathiot C, Coz C, Zucker JM, 
Franks CR, Bouffet E, Philip T: Interleukin 2 immunotherapy in children with 
neuroblastoma after high-dose chemotherapy and autologous bone marrow 
transplantation. Pediatr Hematol Oncol 7:275, 1990. 
32. Favrot M, Bouffet E, Mathiot C, Zucker JM, Coze C, Franks CR, Philip T, Michon 
J: Interleukin 2 (IL2) therapy with or without LAK cell reinjection in 24 children with 
neuroblastoma. Proc Annu Meet Am Soc Clin Oncol 9:A1164, 1990 (abstr.). 
33. Handgretinger R, Bruchelt G, Kimmig A, Lang P, Daurer B, Dopfer R, Treuner J, 
Niethammer D: In vitro and in vivo effect of interleukin-2 on the 2’,5’-oligoadenylate 
synthetase activity of peripheral mononuclear blood cells. J Interferon Res 10:75, 1990. 
[764] 
Recombinant DNA Research, Volume 15 
